L Hood

803 total citations
15 papers, 609 citations indexed

About

L Hood is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Pathology and Forensic Medicine. According to data from OpenAlex, L Hood has authored 15 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 4 papers in Pediatrics, Perinatology and Child Health and 3 papers in Pathology and Forensic Medicine. Recurrent topics in L Hood's work include Cancer survivorship and care (6 papers), Childhood Cancer Survivors' Quality of Life (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). L Hood is often cited by papers focused on Cancer survivorship and care (6 papers), Childhood Cancer Survivors' Quality of Life (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). L Hood collaborates with scholars based in United States. L Hood's co-authors include Susan Schneider, Susan L. Beck, Sandra A. Mitchell, John László, Amy P. Abernethy, James E. Herndon, Jane L. Wheeler, Meenal Patwardhan, H. Kim Lyerly and Heather Shaw and has published in prestigious journals such as Journal of Clinical Oncology, Biological Psychiatry and Journal of Pain and Symptom Management.

In The Last Decade

L Hood

15 papers receiving 577 citations

Peers

L Hood
Meeke Hoedjes Netherlands
Ssf Leung Hong Kong
Sandahl H. Nelson United States
D. Storey United Kingdom
Dounya Schoormans Netherlands
Krista Payne United States
Maria Cho United States
Aasha I. Hoogland United States
Mary Panjari Australia
L Hood
Citations per year, relative to L Hood L Hood (= 1×) peers Pei‐Ling Tang

Countries citing papers authored by L Hood

Since Specialization
Citations

This map shows the geographic impact of L Hood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Hood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Hood more than expected).

Fields of papers citing papers by L Hood

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Hood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Hood. The network helps show where L Hood may publish in the future.

Co-authorship network of co-authors of L Hood

This figure shows the co-authorship network connecting the top 25 collaborators of L Hood. A scholar is included among the top collaborators of L Hood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Hood. L Hood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Wheeler, Jane L., James E. Herndon, April Coan, et al.. (2009). Use of tablet personal computers for sensitive patient-reported information.. PubMed. 7(3). 91–7. 46 indexed citations
2.
Abernethy, Amy P., James E. Herndon, Jane L. Wheeler, et al.. (2009). Feasibility and Acceptability to Patients of a Longitudinal System for Evaluating Cancer-Related Symptoms and Quality of Life: Pilot Study of an e/Tablet Data-Collection System in Academic Oncology. Journal of Pain and Symptom Management. 37(6). 1027–1038. 113 indexed citations
3.
Schneider, Susan & L Hood. (2007). Virtual Reality: A Distraction Intervention for Chemotherapy. Oncology nursing forum. 34(1). 39–46. 139 indexed citations
4.
Mitchell, Sandra A., et al.. (2007). Putting Evidence Into Practice: Evidence-Based Interventions for Fatigue During and Following Cancer and Its Treatment. Clinical journal of oncology nursing. 11(1). 99–113. 130 indexed citations
5.
Abernethy, Amy P., Jeannette M. Day, L Hood, et al.. (2007). E-tablets to collect research-quality patient-reported data. Journal of Clinical Oncology. 25(18_suppl). 6609–6609. 3 indexed citations
6.
Hood, L. (2003). Chemotherapy in the Elderly: Supportive Measures for Chemotherapy-Induced Myelotoxicity. Clinical journal of oncology nursing. 7(2). 185–190. 8 indexed citations
7.
McBride, Colleen M., Kathryn I. Pollak, Jennifer Garst, et al.. (2003). Distress and Motivation for Smoking Cessation among Lung Cancer Patients' Relatives Who Smoke. Journal of Cancer Education. 18(3). 150–156. 19 indexed citations
8.
Piper, Barbara F., et al.. (1990). Recent advances in the management of biotherapy-related side effects: fatigue.. PubMed. 16(6 Suppl). 27–34. 50 indexed citations
9.
László, John, Daniel A. Goldstein, Jon P. Gockerman, et al.. (1990). Phase I studies of recombinant interferon-gamma.. PubMed. 9(2). 185–93. 4 indexed citations
10.
Krishnan, Ranga, Everett H. Ellinwood, John László, L Hood, & James Ritchie. (1987). Effect of gamma interferon on the hypothalamic-pituitary-adrenal system. Biological Psychiatry. 22(9). 1163–1166. 18 indexed citations
11.
Goldstein, Daniel A., Jon P. Gockerman, Ranga Krishnan, et al.. (1987). Effects of gamma-interferon on the endocrine system: results from a phase I study.. PubMed. 47(23). 6397–401. 36 indexed citations
12.
László, John, et al.. (1986). Does maintenance therapy with alpha interferon stabilize cancer growth? A pilot study.. PubMed. 5(4). 294–9. 1 indexed citations
13.
Vugrin, Davor, L Hood, & John László. (1986). A phase II trial of high-dose human lymphoblastoid alpha interferon in patients with advanced renal carcinoma.. PubMed. 5(4). 309–12. 7 indexed citations
14.
László, John, L Hood, Eric Cox, & Belinda C. Goodwin. (1986). A randomized trial of low doses of alpha interferon in patients with breast cancer.. PubMed. 5(3). 206–10. 5 indexed citations
15.
Vugrin, Davor, L Hood, W. Chris Taylor, & John László. (1985). Phase II study of human lymphoblastoid interferon in patients with advanced renal carcinoma.. PubMed. 69(7-8). 817–20. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026